Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Jaguar Gene Therapy LLC currently maintains a company patent portfolio with 1 pending office action. The prosecution is handled by 1 distinct examiner. The data indicates that there are 0 distinct art units associated with this pending action, which simplifies the administrative tracking of the case.
YU, DELPHINUS DOU YI is the busiest examiner among the 1 distinct examiners for this portfolio, as he is responsible for the 1 pending office action currently on record. Because there is only 1 distinct examiner involved, the prosecution environment is entirely centralized. Practitioners can dedicate their resources to understanding the specific preferences and historical trends associated with YU, DELPHINUS DOU YI.
The outcome of this 1 pending office action will define the immediate success of the portfolio. The lack of multiple examiners or art units removes the need for cross-unit coordination in the current strategy. This streamlined profile allows for a highly targeted approach to the active matter, ensuring that all efforts are aligned with the requirements of the single examiner involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YU, DELPHINUS DOU YI | 1 | 33.3% | +0.0% |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18687808 | ADENO-ASSOCIATED VECTORS AND VIRIONS TO TREAT GALACTOSEMIA AND METHODS OF USE AND MANUFACTURE | YU, DELPHINUS DOU YI | — | §102§103§112DPOther | Non-Final OA | — | Pending | Feb 28, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial